Stay updated on Long-term Safety of KarXT in Schizophrenia Clinical Trial
Sign up to get notified when there's something new on the Long-term Safety of KarXT in Schizophrenia Clinical Trial page.

Latest updates to the Long-term Safety of KarXT in Schizophrenia Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedNew revision entry v3.5.4 was added to the record history, replacing the prior v3.5.3. This reflects an updated version of the study record without changing the reported study details.SummaryDifference0.2%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedA new revision label, v3.5.3, was added to the Record History and the previous label, v3.5.2, was removed, reflecting an update to the page's revision history.SummaryDifference0.1%

- Check47 days agoChange DetectedA new history entry Revision: v3.5.2 was added and Revision: v3.5.0 was removed from the study record history.SummaryDifference0.1%

- Check62 days agoChange DetectedSponsor name updated to Karuna Therapeutics, Inc., a Bristol Myers Squibb company, replacing Karuna Therapeutics.SummaryDifference0.2%

- Check76 days agoChange DetectedA new revision entry, v3.5.0, was added. The previous revision, v3.4.3, was removed from the Record History.SummaryDifference0.1%

- Check83 days agoChange DetectedA new revision entry v3.4.3 was added to the record history, and the previous revision v3.4.2 was removed from view.SummaryDifference0.1%

Stay in the know with updates to Long-term Safety of KarXT in Schizophrenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-term Safety of KarXT in Schizophrenia Clinical Trial page.